trending Market Intelligence /marketintelligence/en/news-insights/trending/5WbX76Pruu78R4INtKe69w2 content esgSubNav
In This List

Catalyst Biosciences closes common stock offering

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Catalyst Biosciences closes common stock offering

Catalyst Biosciences Inc. closed its underwritten public offering of 1,105,263 common shares at $9.50 apiece with gross proceeds of about $10.5 million.

JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. acted as joint book-running managers. LifeSci Capital LLC served as a co-manager for the offering.